Synapse - Works

Results (2969)

PLX4032 in metastatic colorectal cancer patients with mutant BRAF tumors

Meeting Abstract

Kopetz, S.; Desai, J.; Chan, E.; Hecht, J. R.; O'Dwyer, P. J.; Lee, R. J.; Nolop, K. B.; Saltz, L.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Intensity-modulated radiotherapy for esophageal cancer: Analysis of toxicity and outcomes

Meeting Abstract

Kurshan, N.; Ilson, D.; Shah, M. A.; Kelsen, D. P.; Ho, A. Y.; Zhang, Z.; Mo, Q.; Goodman, K. A.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Initial results of LC-MAP: An institutional program to routinely profile tumor specimens for the presence of mutations in targetable pathways in all patients with lung adenocarcinoma

Meeting Abstract

Kris, M. G.; Lau, C. Y.; Ang, D.; Brzostowski, E.; Riely, G. J.; Rusch, V. W.; Jhanwar, S.; Lash, A.; Zakowski, M. F.; Ladanyi, M.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Phase II trial of continuous low-dose temozolomide (TMZ) for recurrent malignant glioma (MG) with and without prior exposure to bevacizumab (BEV)

Meeting Abstract

Khasraw, M.; Abrey, L. E.; Lassman, A. B.; Hormigo, A.; Nolan, C.; Gavrilovic, I. T.; Mellinghoff, I. K.; Reiner, A. S.; DeAngelis, L. M.; Omuro, A. M.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

A randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer

Meeting Abstract

Kemeny, N. E.; Jarnagin, W. R.; Capanu, M.; Fong, Y.; Gewirtz, A.; DeMatteo, R. P.; D'Angelica, M. I.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Randomized phase II trial of erlotinib (E) alone or in combination with carboplatin/paclitaxel (CP) in never or light former smokers with advanced lung adenocarinoma: CALGB 30406

Meeting Abstract

Janne, P. A.; Wang, X. F.; Socinski, M. A.; Crawford, J.; Capelletti, M.; Edelman, M. J.; Villalona-Calero, M. A.; Kratzke, R. A.; Vokes, E. E.; Miller, V. A.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Prevalence of memory problems that limit daily functioning in adult cancer patients: A national representative sample of the US population

Meeting Abstract

Jean-Pierre, P.; Winters, P.; Ahles, T.; Antoni, M.; Armstrong, D.; Penedo, F.; Lipshultz, S. E.; Miller, T. L.; Morrow, G. R.; Fiscella, K.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Duodenal follicular lymphoma: Clinical and pathologic characteristics, management, and outcomes

Meeting Abstract

Jhaveri, A. P.; Maragulia, J.; Zelenetz, A. D.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Overall survival (OS) in ATLAS, a phase IIIb trial comparing bevacizumab (B) therapy with or without erlotinib (E) after completion of chemotherapy (chemo) with B for first-line treatment of locally advanced, recurrent, or metastatic non-small cell lung cancer (NSCLC)

Meeting Abstract

Kabbinavar, F. F.; Miller, V. A.; Johnson, B. E.; O'Connor, P. G.; Soh, C.; for the ATLAS Investigators
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinoma

Meeting Abstract

Johnson, M. L.; Sima, C.; Paik, P. K.; Janjigian, Y. Y.; Pao, W.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save